Arguably, 2020 was the year of high‐accuracy protein structure predictions, with AlphaFold
2.0 achieving previously unseen accuracy in the Critical Assessment of Protein Structure …

Because vaccine development is a difficult process, this study reviews aspects of phages as
vaccine delivery vehicles through a literature search. The results demonstrated that because …

The archiving and dissemination of protein and nucleic acid structures as well as their
structural, functional and biophysical annotations is an essential task that enables the …

The versatile potential of bacteriophage MS2-derived virus-like particles (VLPs) in medical
biotechnology has been extensively studied during the last 30 years. Since the first reports …

To search for subunit vaccine candidates, immunogenic chlamydial antigens identified in
humans were evaluated for protection against both infection and pathology in a mouse …

Virus-like particles (VLPs) are nanostructures with the potential to present heterologous
peptides at high density, thereby triggering heightened immunogenicity. RNA bacteriophage …

Virus-like particles (VLPs) derived from bacteriophages have many applications in
biomedical sciences, especially in the development of candidate vaccines against viral and …

Chlamydia (C.) trachomatis, a leading cause of sexually transmitted infections (STIs)
worldwide, continues to be a significant public health concern. The majority of infections are …

Opioid use disorder (OUD) and opioid overdoses are public health emergencies. In 2021,
80,000 opioid overdose associated deaths were reported in the United States. Despite the …

To begin to optimize the immunization routes for our reported PLGA-rMOMP nanovaccine
[PLGA-encapsulated Chlamydia muridarum (Cm) recombinant major outer membrane …